Assignee
ZHEJIANG SHIMAI PHARMACEUTICAL CO LTD
CN·5 granted patents·3 pending applications·7 citations·filing 2018–2022
Top patents by PatentIndex Score
8 records- 0189US11578139B1Antibodies against ENPP3 and uses thereofZHEJIANG SHIMAI PHARMACEUTICAL CO LTD·Filed 2022·Granted Feb 14, 2023·6 cites·23 claims
- 0276US11339218B2Human monoclonal antibodies against LAG3 and uses thereofZHEJIANG SHIMAI PHARMACEUTICAL CO LTD·Filed 2018·Granted May 24, 2022·1 cites·21 claims
- 0367US11766479B1Therapeutic use of antibodies against ENPP3ZHEJIANG SHIMAI PHARMACEUTICAL CO LTD·Filed 2022·Granted Sep 26, 2023·0 cites·20 claims
- 0466US12325758B2Protease cleavable bispecific antibodies and uses thereofZHEJIANG SHIMAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Jun 10, 2025·0 cites·15 claims
- 0560US12325757B2Protease cleavable bispecific antibodies and uses thereofZHEJIANG SHIMAI PHARMACEUTICAL CO LTD·Filed 2019·Granted Jun 10, 2025·0 cites·5 claims
- 0656US2025361299A1Protease cleavable recombinant bispecific antibodies and compositions and uses thereofZHEJIANG SHIMAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0753US2024309116A1Antibodies against ror1 and uses thereofZHEJIANG SHIMAI PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0851US2024368303A1Antibodies against gpc3 and uses thereofZHEJIANG SHIMAI PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ZHEJIANG SHIMAI PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →